Services

City medtech secures investment of €6.4m to advance revolutionary stroke treatment

Published:

City medtech secures investment of €6.4m to advance revolutionary stroke treatment

A city-based medtech firm has secured investment of €6.4m to advance a revolutionary new stroke treatment.

Ceroflo will use the latest funding to advance an innovative stent that works to prevent one of the leading causes of stroke.


(adsbygoogle = window.adsbygoogle || []).push({});

That’s Intracranial atherosclerotic disease – or IACD.

The €6.4m will now allow Ceroflo to bring the stent to 30 patients in the first human trials.

 

The post City medtech secures investment of €6.4m to advance revolutionary stroke treatment appeared first on Galway Bay FM.

More like this:

Sign Up To get Weekly Sports UPDATES

Go Up